LinkedIn IconTwitter Icon

27-29 November 2018
Berlin, Germany

Speakers

Expand/Collapse

Craig Blanchette
Senior Scientist
Genentech

Mathieu Blery
Senior Director, Translational Immunology
Innate Pharma

Jannie Borst
Head, Division of Tumor Biology and Immunology
Netherlands Cancer Institute

Tanja de Gruijl
Professor, Translational Tumor Immunology & Head of Immunotherapy Lab
VU University Medical Center

Wolf-Dietrich Doecke
Director, Biomarker Strategist
Bayer

Walter Ferlin
Head of Exploratory Science & Translational Medicine
NovImmune

Tina Furebring
Vice President, Research & Development, Research
Alligator Bioscience

Laura Helming
Director, Scientific Site Head, Immuno-Oncology
Merck KGaA

Marlon Hinner
Group Leader, In Vitro Display
Roche

Christian Hosius
Regional Director, Medical Affairs, Oncology
Merck Sharpe & Dohme

Zoë Johnson
CSO
iOnctura

Reece Marillier
Research Scientists, In Vivo Pharmacology
iTeos Therapeutics

Nicolo Rigamonti
Biology Lead & Project Leader, Cancer Immunology
Molecular Partners

Kris Sachsenmeier
Associate Director, Translational Science, IMED Oncology
AstraZeneca

Zhen Su
Senior Vice President & Chief Medical Officer
Merck KGaA

Tim Sullivan
Vice President, Business Development
Vice President, Business Development

Frederic Triebel
CSO & CMO
Immutep

Markus Zettl
Director, Immuno-Oncology
Pieris Pharmaceuticals

Speaker to be confirmed

Personalis